El Instituto de Neurociencias de Castilla y León (INCYL) trabaja en una línea de investigación contra el glioblastoma y ha logrado resultados prometedores
Read moreLa investigación se centra en esta región cerebral, su conectividad y su fisiología para buscar nuevas herramientas terapéuticas y diagnósticas de la esquizofrenia
Read moreAn international study involving Marina Mitjans, a researcher at the Sant Joan de Déu Research Institute (IRSJD), the UB Institute of Biomedicine (IBUB), and the Biomedical Research Networking Center...
Read morePublished in Cell Reports Medicine*, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation sequencing (NGS) for precise patient stratification and tr...
Read moreScientists from the ibs.GRANADA and the UGR participate in the largest international genetic research on depression
Read moreEste estudio ha revelado que APE1, una proteína característica de mamíferos esencial para mantener la estabilidad del ADN y una diana prometedora para el desarrollo de tratamientos contra el cánce...
Read moreThe explosion of the genomic era shows that gene loss and simplification is a much more frequent process in the evolution of species than previously thought, and may favour new biological adaptations ...
Read morePublished in the journal Nature Communications*, results from a first-in-human, phase I clinical trial of an oral, potent and reversible inhibitor of methionine adenosyltransferase 2 A (MT2A)—a key ...
Read moreThe results of this research highlight the need for a broader genetic analysis to be able to better identify carriers of pathogenic variants of this gene, improving early diagnosis.
Read moreThe results of this trial will be crucial in understanding the molecular changes that may contribute to the development of benign and malignant breast lesions, and in the future, help to properly inte...
Read moreResearchers have successfully uncovered the molecular mechanisms by which bacterial cellulose patches stimulate the regeneration of plant wounds.
Read moreLos resultados del ensayo de fase III TALAPRO-2, en que participa el VHIO, demuestran que la combinación de talazoparib más enzalutamida frente al tratamiento estándar de enzalutamida mejora signif...
Read more